Page de couverture de The Mortar & Pestle

The Mortar & Pestle

The Mortar & Pestle

Auteur(s): PCCA - The Leader in Compounding Pharmacy
Écouter gratuitement

À propos de cet audio

 A podcast for pharmacy focusing on compounding personalized medicine, nutrition, marketing your business, and all things pharmacy..Copyright 2022 All rights reserved. Chimie Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Methylene Blue Topical Formulations and Advanced Dermatology Compounding Strategies with Nat Jones

    Methylene Blue Topical Formulations and Advanced Dermatology Compounding Strategies with Nat Jones
    Jan 29 2026
    In this episode, discover innovative dermatology compounding formulations featuring methylene blue for anti-aging skincare. Clinical pharmacist Nat Jones discusses PCCA's USP-grade methylene and the need for quality. Methylene blue may play a role in collagen stimulation, hyaluronic acid production, and UV protection. Also, learn about bio-peptide cream bases, research on carbamazepine and plaque psoriasis as well as research on losartan and hypertrophic scars. Explore evidence-based topical treatments that may be appropriate for patients in compounding pharmacies. Perfect for pharmacists seeking advanced dermatological formulation strategies and cosmeceutical applications.

    Learn more by visiting our blog: Methylene Blue: Something Old and Something Blue

    Working with Methylene Blue: Best Practices for Compounding and Cleanup

    Methylene Blue: From Textile Dye to Potential Clinical Wonder
    Voir plus Voir moins
    26 min
  • Industry Leader: APC Blue Print with Tenille Davis and Erin Micheal

    Industry Leader: APC Blue Print with Tenille Davis and Erin Micheal
    Nov 3 2025

    In this episode of a Mortar and Pestle, Tenille Davis, Chief Advocacy Officer for the Alliance for Pharmacy Compounding, joins host Mike De Lisio and guest co-host Erin Michael, Director of Member Engagement, to discuss the APC Blue Print, a blueprint for eliminating redundant, unauthorized, or ineffective regulation that impedes patient access to compounded drugs.
    Voir plus Voir moins
    23 min
  • Introducing UniFlow with Courtaney Davis and Daniel Banov

    Introducing UniFlow with Courtaney Davis and Daniel Banov
    Oct 9 2025

    In this episode of a Mortar and Pestle, Vice President of Research and Development Daniel Banov and Senior Formulation Specialist Courtaney Davis join host Vice President of North American Sales Mike De Lisio and co-host Clinical Compounding Pharmacist, RPh, FAARM (Candidate) Sebastian Denison, to discuss PCCA’s newest base innovation, UniFlow ­— a game changer in T3 and T4 compounding.
    Voir plus Voir moins
    40 min
Pas encore de commentaire